J B Chemicals & Pharmaceuticals Ltd - J B CHEM & PHARM Share Price

Sector: Pharmaceuticals | ISIN: INE572A01028
₹ 1,799.80 (2.36%) icon12 Apr, 2024, 12:00:00 AM
Open
₹ 1,759.95
Prev. Close
₹ 1,758.30
Turnover(lac)
₹ 0.08
Day's High
₹ 1,810.00
Day's Low
₹ 1,736.00
52 Wk High
₹ 1,940.00
52 Wk Low
₹ 875.00
Book Value
₹ 184.28
Face Value
₹ 1.00
Mkt. Cap (Cr.)
₹ 27,931.96
P/E
55.20
EPS
32.62
Div. Yield
0.49

J B Chemicals & Pharmaceuticals Ltd KEY RATIOS

sector: Pharmaceuticals

  • CMP

    as on 4/12/2024 12:00:00 AM

    ₹ 1799.8 41.50 2.36
  • Open
  • ₹ 1,759.95
  • Prev. Close
  • ₹ 1,758.3
  • Turnover(Lac.)
  • ₹ 0
  • Day's High
  • ₹ 1,810
  • Day's Low
  • ₹ 1,736
  • 52 Week's High
  • ₹ 1,940
  • 52 Week's Low
  • ₹ 875
  • Book Value
  • ₹ 184.28
  • Face Value
  • ₹ 1
  • Mkt Cap (₹ Cr.)
  • 27,931.96
  • P/E
  • 55.2
  • EPS
  • 32.62
  • Divi. Yield
  • 0.49

J B Chemicals & Pharmaceuticals Ltd Corporate Actions

06 Feb , 2024

12:00 AM

Dividend

Dividend amount: 5.5
Announcement date: 06 Feb , 2024

View Details

30 Jan , 2024

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

30 Jan , 2024

12:00 AM

30 Oct , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

30 Oct , 2023

12:00 AM

24 May , 2023

12:00 AM

30 Jun , 2023

12:00 AM

AGM

Announcement date: 30 Jun , 2023

View Details

24 May , 2023

12:00 AM

Dividend

Dividend amount: 9.25
Announcement date: 24 May , 2023

View Details

01 Aug , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

01 Aug , 2023

12:00 AM

08 May , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

28 Jul , 2023

12:00 AM

BookCloser

View Details

No Record Found


J B Chemicals & Pharmaceuticals Ltd News and Update

No Record Found

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required

J B Chemicals & Pharmaceuticals Ltd SHAREHOLDING SNAPSHOT
13 April , 2024 | 06:23 PM

PROMOTER - TOTAL53.83%

Indian: 0.00%

Foreign: 53.8328%

NON-PROMOTER - TOTAL 46.17%

Institutions: 28.89%

Non-Institutions: 17.28%

CUSTODIES - 0.00%

Custodies: 0.00%

See More Details
ad IconAd Image

J B Chemicals & Pharmaceuticals Ltd FINANCIALS

J B Chemicals & Pharmaceuticals Ltd PEER COMPARISON

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.View All Peer Comparison

MORE ABOUT J B Chemicals & Pharmaceuticals Ltd

  • Padmini Khare Kaicker
  • Non-Exec. & Independent Dir.
  • Sumit Bose
  • Non-Exec. & Independent Dir.
  • Ranjit Shahani.
  • Chairman & Independent Directo
  • Prashant Kumar.
  • Non-Exec & Non-Independent Dir
  • Nikhil Chopra
  • Whole Time Director & CEO
  • GAURAV TREHAN
  • Non-Exec & Non-Independent Dir
  • SANDEEP PHADNIS
  • Company Sec. & Compli. Officer

Summary

J B Chemicals & Pharmaceuticals (JBC) was originally promoted and incorporated in Maharashtra by J B Mody as J B Mody Chemicals & Pharmaceuticals in December 18th, 1976. The Company is engaged in the business of manufacturing and marketing of diverse range of pharmaceuticals formulations, herbal remedies and APIs. The company has manufacturing units at Thane, Belapur, Ankleshwar, Panoli and Daman. The bulk drug plant at Panoli and formulation plant at Daman became operational in Apr.95. Products like metrogyl, rantac (a ranitidine-based formulation), and nicardia (a cardiac care medicine) form a significant part of the companys sales. JBC has its subsidiaries namely Lekar Healthcare Ltd and J.B Life Science Overseas Ltd. JBC had a tie-up with Justesa Imagen, Spain, to manufacture and market radio diagnostics under the Trazograf brand name. JBC has also diversified into high-growth agro-based products by acquiring McDa Agro (MAL). The products manufactured by MAL complement fertilisers and increase crop productivity. It has entered into a MoU with GNFC to distribute these products locally. The pharmaceutical divisions of Ifiunik Pharmaceuticals and Unique Pharmaceutical Laboratories has been merged into the company with effect from April 2000.Unique Chemicals (A Division of the company) manufacturing and marketing Bulk Drugs has been awarded Certificate of Suitability to Europeon Pharmacopoeia Monograph for Nifedipine EP from Europeon Directorate for the Quality Medicines.In... Read More


Reports by J B Chemicals & Pharmaceuticals Ltd


Reports by J B Chemicals & Pharmaceuticals Ltd

Company FAQ

No Record Found